Financial Incentive–Based Approaches for Weight Loss: A Randomized Trial | Lifestyle Behaviors | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.234.102. Please contact the publisher to request reinstatement.
1.
Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000.  JAMA. 2002;288(14):1723-172712365955PubMedGoogle ScholarCrossref
2.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004.  JAMA. 2006;295(13):1549-155516595758PubMedGoogle ScholarCrossref
3.
Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity.  JAMA. 2005;293(15):1861-186715840860PubMedGoogle ScholarCrossref
4.
Laibson DI. Golden eggs and hyperbolic discounting.  Q J Econ. 1997;112(2):443-477Google ScholarCrossref
5.
O'Donoghue T, Rabin M. Doing it now or later.  Am Econ Rev. 1999;89(1):103-124Google ScholarCrossref
6.
Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors.  JAMA. 2007;298(20):2415-241718042920PubMedGoogle ScholarCrossref
7.
Ryan DH, Espeland MA, Foster GD,  et al.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.  Control Clin Trials. 2003;24(5):610-62814500058PubMedGoogle ScholarCrossref
8.
National Institutes of Health.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults–The Evidence Report [published correction appears in Obes Res. 1998;6(6):464]  Obes Res. 1998;6:(suppl 2)  51S-209S9813653PubMedGoogle ScholarCrossref
9.
Knowler WC, Barrett-Connor E, Fowler SE,  et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.  N Engl J Med. 2002;346(6):393-40311832527PubMedGoogle ScholarCrossref
10.
Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity, Institute of Medicine.  Weighing the Options: Criteria for Evaluating Weight-Management Programs. Thomas PR, ed; Washington, DC: National Academies Press; 1995
11.
Finkelstein EA, Linnan LA, Tate DF, Birken BE. A pilot study testing the effect of different levels of financial incentives on weight loss among overweight employees.  J Occup Environ Med. 2007;49(9):981-98917848854PubMedGoogle ScholarCrossref
12.
Jeffery RW, Gerber WM, Rosenthal BS, Lindquist RA. Monetary contracts in weight control: effectiveness of group and individual contracts of varying size.  J Consult Clin Psychol. 1983;51(2):242-2486841768PubMedGoogle ScholarCrossref
13.
Jeffery RW, Thompson PD, Wing RR. Effects on weight reduction of strong monetary contracts for calorie restriction or weight loss.  Behav Res Ther. 1978;16(5):363-369743075PubMedGoogle ScholarCrossref
14.
Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.  J Consult Clin Psychol. 2000;68(1):64-7210710841PubMedGoogle ScholarCrossref
15.
Sindelar JL. Paying for performance: the power of incentives over habits.  Health Econ. 2008;17(4):449-45118348117PubMedGoogle ScholarCrossref
16.
Higgins ST. Applying behavioral economics to the challenge of reducing cocaine abuse. In: Chaloupka FJ, Grossman M, Bickel WK, Saffer H, eds. The Economic Analysis of Substance Use and Abuse. Cambridge, MA: National Bureau of Economic Research; 1999:157-174
17.
Giuffrida A, Torgenson DJ. Should we pay the patient? review of financial incentives to enhance patient compliance.  BMJ. 1997;315(7110):703-7079314754PubMedGoogle ScholarCrossref
18.
Volpp KG, Pauly MV, Loewenstein G, Bangsberg D. P4P4P: an agenda for research on pay for performance for patients.  Health Aff (Millwood)In press8375823PubMedGoogle Scholar
19.
Schroeder SA. We can do better—improving the health of the American people.  N Engl J Med. 2007;357(12):1221-122817881753PubMedGoogle ScholarCrossref
20.
Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control.  Psychol Bull. 1975;82(4):463-4961099599PubMedGoogle ScholarCrossref
21.
Thaler RH. Some empirical evidence on dynamic inconsistency [letter].  Economics Stud. 1981;23:201-207Google Scholar
22.
Loewenstein G, Prelec D. Anomalies in intertemporal choice: evidence and an interpretation.  Q J Econ. 1992;107(2):573-597Google ScholarCrossref
23.
Kirby K. Bidding on the future: evidence against normative discounting of delayed rewards.  J Exp Psychol Gen. 1997;126(1):54-70Google ScholarCrossref
24.
Camerer C, Ho T-H. Experience-weighted attraction: learning in normal form games.  Econometrica. 1999;67(4):837-874Google ScholarCrossref
25.
Loewenstein GF, Weber EU, Hsee CK, Welch N. Risk as feelings.  Psychol Bull. 2001;127(2):267-28611316014PubMedGoogle ScholarCrossref
26.
Connolly T, Butler DU. Regret in economic and psychological theories of choice.  J Behav Decis Making. 2006;19(2):139-158Google ScholarCrossref
27.
Chapman GB, Coups EJ. Emotions and preventive health behavior: worry, regret, and influenza vaccination.  Health Psychol. 2006;25(1):82-9016448301PubMedGoogle ScholarCrossref
28.
Bandura A. Principles of Behavior Modification. New York, NY: Holt, Rinehart and Winston, Inc; 1969
29.
Kahneman DR, Tversky A. Prospect theory: an analysis of decision under risk.  Econometrica. 1979;47(2):263-291Google ScholarCrossref
30.
Thaler RH, Tversky A, Kahneman DR, The AS. The effect of myopia and loss aversion on risk taking: an experimental test.  Q J Econ. 1997;112(2):647-661Google ScholarCrossref
31.
Rizzo JA, Zeckhauser RJ. Reference incomes, loss aversion, and physician behavior.  Rev Econ Stat. 2003;85(4):909-922Google ScholarCrossref
32.
Camerer C. Three cheers—psychological, theoretical, empirical—for loss aversion.  J Mark Res. 2005;42(2):129-133Google ScholarCrossref
33.
Read D, Loewenstein G, Rabin M. Choice bracketing.  J Risk Uncertain. 1999;19(1-3):171-197Google ScholarCrossref
34.
McTigue KM, Harris R, Hemphill B,  et al.  Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force.  Ann Intern Med. 2003;139(11):933-94914644897PubMedGoogle ScholarCrossref
35.
 Strategic plan for NIH Obesity Research: A report of the NIH Obesity Research Task Force. August 2006; http://www.obesityresearch.nih.gov.Accessed September 29, 2008
36.
 Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization; 1998
37.
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States.  JAMA. 2001;286(10):1195-120011559264PubMedGoogle ScholarCrossref
38.
Encinosa WE, Bernard DM, Chen CC, Steiner CA. Healthcare utilization and outcomes after bariatric surgery.  Med Care. 2006;44(8):706-71216862031PubMedGoogle ScholarCrossref
Preliminary Communication
December 10, 2008

Financial Incentive–Based Approaches for Weight Loss: A Randomized Trial

Author Affiliations

Author Affiliations: Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia (Dr Volpp and Ms Norton); Center for Health Incentives, Leonard Davis Institute of Health Economics (Drs Volpp, Troxel, and Loewenstein and Ms Norton), Department of Medicine, University of Pennsylvania School of Medicine (Dr Volpp and Ms Norton), Department of Health Care Management, the Wharton School (Dr Volpp), and the Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia (Drs Troxel and Fassbender); and the Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh (Dr Loewenstein and Ms John).

JAMA. 2008;300(22):2631-2637. doi:10.1001/jama.2008.804
Abstract

Context Identifying effective obesity treatment is both a clinical challenge and a public health priority due to the health consequences of obesity.

Objective To determine whether common decision errors identified by behavioral economists such as prospect theory, loss aversion, and regret could be used to design an effective weight loss intervention.

Design, Setting, and Participants Fifty-seven healthy participants aged 30-70 years with a body mass index of 30-40 were randomized to 3 weight loss plans: monthly weigh-ins, a lottery incentive program, or a deposit contract that allowed for participant matching, with a weight loss goal of 1 lb (0.45 kg) a week for 16 weeks. Participants were recruited May-August 2007 at the Philadelphia VA Medical Center in Pennsylvania and were followed up through June 2008.

Main Outcome Measures Weight loss after 16 weeks.

Results The incentive groups lost significantly more weight than the control group (mean, 3.9 lb). Compared with the control group, the lottery group lost a mean of 13.1 lb (95% confidence interval [CI] of the difference in means, 1.95-16.40; P=.02) and the deposit contract group lost a mean of 14.0 lb (95% CI of the difference in means, 3.69-16.43; P =.006). About half of those in both incentive groups met the 16-lb target weight loss: 47.4% (95% CI, 24.5%-71.1%) in the deposit contract group and 52.6% (95% CI, 28.9%-75.6%) in the lottery group, whereas 10.5% (95% CI, 1.3%- 33.1%; P = .01) in the control group met the 16-lb target. Although the net weight loss between enrollment in the study and at the end of 7 months was larger in the incentive groups (9.2 lb; t = 1.21; 95% CI, −3.20 to 12.66; P = .23, in the lottery group and 6.2 lb; t = 0.52; 95% CI, −5.17 to 8.75; P = .61 in the deposit contract group) than in the control group (4.4 lb), these differences were not statistically significant. However, incentive participants weighed significantly less at 7 months than at the study start (P = .01 for the lottery group; P = .03 for the deposit contract group) whereas controls did not.

Conclusions The use of economic incentives produced significant weight loss during the 16 weeks of intervention that was not fully sustained. The longer-term use of incentives should be evaluated.

Trial Registration clinicaltrials.gov Identifier: NCT00520611

×